background
nosocomi
infect
major
threat
patient
intens
care
unit
icu
limit
data
exist
epidemiolog
icuacquir
infect
china
retrospect
studi
carri
determin
current
statu
nosocomi
infect
china
retrospect
review
nococomi
infect
icu
tertiari
hospit
east
china
perform
nosocomi
infect
defin
accord
definit
center
diseas
control
prevent
overal
patient
nosocomi
infect
rate
incid
densiti
rate
nosocomi
infect
excess
length
stay
distribut
nosocomi
infect
site
determin
pathogen
antimicrobi
suscept
profil
investig
result
among
patient
admit
period
time
overal
patient
nosocomi
infect
rate
per
patient
day
lower
respiratori
tract
infect
lrti
account
infect
follow
urinari
tract
infect
uti
bloodstream
bsi
gastrointestin
tract
gi
infect
signific
chang
lrti
uti
bsi
infect
rate
year
howev
gi
rate
significantli
decreas
addit
baumannii
c
albican
epidermidi
frequent
pathogen
isol
patient
lrti
uti
bsi
respect
rate
isol
resist
commonli
use
antibiot
rang
high
rel
stabl
rate
nosocomi
infect
icu
tertiari
hospit
china
year
differ
distribut
infect
site
pathogen
antibiot
suscept
profil
report
western
countri
guidelin
surveil
prevent
nosocomi
infect
must
implement
order
reduc
rate
nosocomi
infect
also
call
healthcar
acquir
infect
health
careassoci
infect
defin
cdc
local
system
condit
result
advers
reaction
presenc
infecti
agent
toxin
without
evid
infect
present
incub
time
admiss
acut
care
set
nosocomi
infect
becom
import
public
health
issu
worldwid
nosocomi
infect
may
result
excess
length
stay
hospit
day
increas
cost
hospit
nosocomi
infect
pose
critic
threat
patient
especi
highrisk
depart
intens
care
unit
icu
industri
countri
nosocomi
infect
occur
hospit
patient
rate
icu
rate
hospit
patient
rate
icu
china
hospit
signific
differ
among
size
facil
administr
teach
research
academ
level
studi
report
nosocomi
infect
china
studi
limit
small
sampl
size
short
period
time
public
chines
journal
without
english
abstract
recent
carri
retrospect
studi
determin
current
statu
nosocomi
infect
tertiari
hospit
east
china
data
nosocomi
infect
year
retriev
review
overal
patient
nosocomi
infect
rate
incid
densiti
rate
nosocomi
infect
excess
length
stay
distribut
nosocomi
infect
site
determin
pathogen
antimicrobi
suscept
profil
investig
studi
perform
affili
hospit
wenzhou
medic
univers
situat
zhejiang
provinc
east
china
bed
one
mix
icu
bed
sinc
hospit
start
infect
control
program
includ
collect
data
infect
acquir
hospit
present
studi
data
januari
decemb
patient
icu
retriev
infect
control
team
sinc
complet
raw
data
patient
icu
avail
retrospect
studi
approv
medic
ethic
committe
third
affili
hospit
wenzhou
medic
colleg
patient
admit
icu
hour
monitor
nosocomi
infect
defin
accord
american
cdc
infect
develop
within
hour
discharg
icu
also
consid
icuacquir
unless
identifi
caus
discharg
major
nosocomi
infect
includ
lower
respiratori
tract
infect
lrti
urin
tract
infect
uti
bloodstream
infect
bsi
gastrointestin
tract
infect
gi
defin
follow
lrti
refer
lower
respiratori
tract
infect
pneumonia
ie
bronchiti
tracheobronch
bronchiol
tracheiti
without
evid
pneumonia
bsi
refer
laboratoryconfirm
bloodstream
infect
uti
refer
symptomat
urinari
tract
infect
gi
refer
gastrointestin
tract
esophagu
stomach
small
larg
bowel
rectum
infect
exclud
gastroenter
append
detail
criteria
diagnos
nosocomi
infect
describ
cdc
document
data
date
site
infect
patient
demograph
inform
devic
use
collect
infect
moreov
data
isol
pathogen
suscept
test
antimicrobi
agent
avail
also
collect
overal
patient
nosocomi
infect
rate
calcul
divid
total
number
patient
nosocomi
infect
total
number
patient
icu
defin
period
time
ie
year
incid
densiti
rate
nosocomi
infect
calcul
divid
total
number
nosocomi
infect
total
patient
day
defin
period
time
total
patient
day
calcul
summat
day
patient
icu
meantim
length
stay
defin
overal
day
patient
spent
hospit
includ
icu
anoth
depart
patient
transfer
icu
stabil
condit
excess
length
stay
calcul
subtract
averag
length
stay
patient
without
nosocomi
infect
patient
nosocomi
infect
statist
analys
perform
use
spss
softwar
version
spss
inc
chicago
ill
usa
chisquar
test
spearman
rankcorrel
coeffici
appli
appropri
analys
p
valu
less
consid
statist
signific
decemb
medic
data
patient
discharg
hospit
icu
collet
averag
length
stay
day
give
patientday
among
patient
patient
acquir
total
nosocomi
infect
includ
patient
two
infect
patient
three
infect
patient
four
infect
one
patient
five
infect
tabl
overal
patient
nosocomi
infect
rate
rang
among
year
signific
differ
infect
rate
among
year
p
incid
densiti
rate
nosocomi
infect
per
patient
day
rang
among
year
excess
length
stay
day
rang
lower
respiratori
tract
infect
lrti
includ
bronchiti
tracheobronch
pneumonia
common
infect
occur
patient
follow
urin
tract
infect
uti
bloodstream
infect
bsi
among
nosocomi
infect
lrti
account
follow
uti
bsi
gastrointestin
tract
infect
patient
nosocomi
lrti
receiv
mechan
ventil
tracheotomi
infect
wherea
nosocomi
uti
nosocomi
bsi
cathet
associ
tabl
signific
chang
lrti
uti
bsi
rate
year
gi
infect
rate
significantli
decreas
p
wherea
nosocomi
infect
site
increas
significantli
p
nosocomi
infect
rate
surgic
site
skin
soft
tissu
remain
tabl
pathogen
isol
identifi
nosocomi
infect
patient
isol
pathogen
respons
nosocomi
infect
differ
among
infect
site
tabl
patient
lrti
acinetobact
baumannii
klebsiella
pneumonia
frequent
isol
pathogen
follow
pseudomona
aeruginosa
staphylococcu
aureu
account
half
lrti
relat
pathogen
popul
patient
uti
fungi
especi
candida
albican
common
pathogen
follow
escherichia
coli
staphylococcu
epidermidi
e
coli
aureu
first
three
common
pathogen
bsi
addit
baumannii
commonli
isol
uti
bsi
tabl
data
suscept
test
avail
isol
includ
isol
e
coli
isol
aureu
isol
p
aeruginosa
overal
e
coli
isol
resist
trimethoprimsulfamethoxazol
tmpsmx
ciprofloxacin
cefotaxim
amoxicillinclavulan
acid
respect
aureu
isol
sensit
vancomycin
isol
resist
nitrofurantoin
tmpsmx
rifampin
ciprofloxacin
respect
addit
p
aeruginosa
resist
tmpsmx
ciprofloxacin
levofloxacin
respect
see
addit
file
patient
nosocomi
infect
treat
empir
antimicrobi
therapi
accord
antimicrobi
suscept
test
result
avail
present
studi
overal
patient
nosocomi
infect
rate
icu
higher
icu
mani
industri
countri
rate
rang
even
higher
rate
observ
icu
develop
countri
howev
rate
compar
report
latin
american
countri
argentina
brazil
slightli
lower
report
india
year
lowest
rate
report
highest
report
one
plausibl
explan
earli
countri
suffer
outbreak
highli
infecti
pneumonia
name
sever
acut
respiratori
syndrom
sar
due
massiv
campaign
prevent
spread
sar
nosocomi
infect
indirectli
reduc
fatigu
campaign
previou
year
disinfect
steril
procedur
might
loosen
explain
moder
rebound
howev
incid
densiti
rate
nosocomi
infect
lowest
due
consider
longer
stay
patient
icu
tabl
averag
length
stay
hospit
vari
overal
averag
day
gener
agreement
day
report
european
unit
state
much
less
report
taiwan
howev
must
also
mention
sar
outbreak
impact
overal
length
stay
although
averag
stay
icu
day
shortest
among
year
averag
stay
hospit
longest
patient
without
nosocomi
infect
due
isol
polici
impos
special
period
time
distribut
nosocomi
infect
present
studi
differ
report
unit
state
found
lrti
common
infect
icu
account
overal
infect
wherea
uti
frequent
report
infect
icu
unit
state
rate
follow
pneumonia
proport
uti
bsi
present
studi
rel
lower
data
report
unit
state
vs
vs
respect
although
data
europ
reveal
three
common
infect
site
present
studi
absolut
proport
lrti
lower
rate
present
studi
common
reason
propos
studi
mani
western
countri
suggest
nosocomi
lrti
mainli
due
mechan
ventil
china
air
pollut
high
densiti
popul
improp
health
habit
smoke
may
also
account
high
rate
lrti
rate
lrti
slightli
insignificantli
decreas
chang
uti
bsi
rate
year
notabl
gi
rate
significantli
stabli
decreas
everi
year
suggest
improv
environ
food
sanitari
region
sinc
lower
respiratori
tract
urinari
tract
first
two
site
nosocomi
infect
frequent
occur
icu
constitut
nosocomi
infect
effort
later
made
control
two
kind
infect
lead
decreas
rate
lower
respiratori
tract
urinari
tract
infect
correspondingli
increas
rate
nosocomi
infect
site
present
studi
show
three
quarter
lrti
patient
receiv
mechan
ventil
tracheotomi
half
nosocomi
uti
bsi
case
cathet
associ
find
consist
previou
studi
indic
nosocomi
infect
often
associ
use
invas
devic
therefor
effect
reduc
nosocomi
infect
use
invas
devic
minim
specif
disinfect
precaut
taken
devic
applic
present
studi
pathogen
isol
overal
nosocomi
infect
patient
nosocomi
infect
similar
us
report
gramneg
bacteria
account
lrti
present
studi
frequent
pathogen
baumannii
k
pneurnonia
present
studi
wherea
p
aeruginosa
aureu
common
pathogen
us
report
consist
us
report
fungi
frequent
pathogen
nosocomi
uti
candida
account
uti
present
studi
suggest
rel
narrow
profil
pathogen
nosocomi
uti
epidermidi
common
pathogen
bsi
present
studi
us
report
howev
e
coli
instead
enterococci
second
common
pathogen
present
studi
e
coli
common
bacteri
caus
nosocomi
uti
also
frequent
found
bsi
lrti
shown
activ
betalactam
antibiot
e
coli
greatli
reduc
result
betalactamas
product
restor
addit
clavulan
acid
present
studi
e
coli
isol
sensit
formula
amoxicillin
combin
clavulan
acid
e
coli
isol
exhibit
suscept
combin
uk
studi
high
rate
resist
tmpsmx
observ
e
coli
isol
contrast
rate
report
uk
addit
high
proport
e
coli
isol
resist
ciprofloxacin
wherea
rate
less
uk
unit
state
find
indic
treatment
antimicrobi
agent
nosocomi
infect
caus
e
coli
china
like
result
clinic
failur
substanti
proport
patient
also
found
consider
number
p
aeruginosa
isol
resist
fluoroquinolon
ciprofloxacin
levofloxacin
compar
fluoroquinoloneresist
rate
report
patient
icu
eight
develop
countri
much
higher
report
unit
state
aureu
isol
present
studi
sensit
vancomycin
similar
observ
tsuji
et
al
japan
addit
observ
rel
low
resist
rate
nitrofurantoin
tmpsmx
render
antimicrobi
agent
suitabl
empir
treatment
aureu
infect
china
guidelin
surveil
prevent
nosocomi
infect
establish
modifi
howev
surveil
system
control
measur
nosocomi
infect
describ
guidelin
complet
implement
execut
hospit
due
imbalanc
develop
health
care
resourc
within
countri
less
attent
nosocomi
infect
hospit
therefor
believ
nosocomi
infect
rate
must
higher
rural
hospit
even
nontertiari
hospit
addit
due
empir
use
abus
antibiot
proport
antibiot
resist
pathogen
nosocomi
infect
mani
lower
level
hospit
would
also
higher
report
present
studi
notic
although
mortal
rate
patient
nosocomi
infect
mortal
directli
caus
nosocomi
infect
major
reason
observ
would
fact
refractori
nosocomi
infect
rel
less
encount
base
suscept
test
show
pathogen
sensit
mani
commonli
use
antibiot
indic
effect
control
moreov
zhejiang
one
richest
provinc
china
medic
healthcar
system
rel
well
establish
antiinfecti
therapi
big
problem
final
emphas
hospit
tertiari
infecti
hospit
experi
methodolog
facil
combat
variou
infect
includ
nosocomi
infect
present
studi
limit
due
retrospect
natur
first
data
risk
factor
except
use
medic
devic
potenti
associ
nosocomi
infect
avail
factor
may
includ
primari
diseas
admiss
icu
patient
rest
postur
eg
semirecumb
supin
bodi
posit
continu
prophylact
use
antipept
ulcer
drug
util
alcoholbas
handrub
oral
care
need
taken
consider
prospect
studi
second
data
identif
isol
pathogen
suscept
avail
half
nosocomi
infect
would
produc
accur
data
number
increas
final
data
clinic
consequ
avail
case
make
imposs
compar
clinic
outcom
patient
without
nosocomi
infect
howev
present
studi
abl
show
length
stay
hospit
significantli
increas
patient
nosocomi
infect
compar
without
infect
conclus
high
rel
stabl
rate
nosocomi
infect
icu
tertiari
hospit
china
year
differ
distribut
infect
site
pathogen
antibiot
suscept
profil
report
western
countri
guidelin
surveil
prevent
nosocomi
infect
must
implement
nation
wide
order
reduc
rate
